Precision Biosciences (DTIL) Interest Expenses (2018 - 2026)

Precision Biosciences (DTIL) has reported Interest Expenses for 9 consecutive years, with $499000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Interest Expenses rose 3.1% year-over-year to $499000.0; the TTM figure through Mar 2026 stood at $1.8 million (down 8.64% YoY), while the FY2025 annual figure was $145.3 million, up 6.14% from the prior year.
• Interest Expenses grew to $499000.0 in Q1 2026 per DTIL's latest filing, from $281000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $10.4 million in Q2 2024 and bottomed at $281000.0 in Q4 2025.
• Historically, Interest Expenses has averaged $3.2 million across 5 years, with a median of $683000.0 in 2023.
• Annual changes were most pronounced in 2022 — Interest Expenses tumbled 95.02% — and 2024, when it surged 1357.1%.
• Precision Biosciences' Interest Expenses stood at $689000.0 in 2022, then plunged by 45.57% to $375000.0 in 2023, then surged by 39.2% to $522000.0 in 2024, then tumbled by 46.17% to $281000.0 in 2025, then surged by 77.58% to $499000.0 in 2026.
• Business Quant data shows DTIL's Interest Expenses at $499000.0 in Q1 2026, $281000.0 in Q4 2025, and $8.0 million in Q3 2025.